I-Corps: Commercialization of new anion-sensing materials

I-Corps:新型阴离子传感材料的商业化

基本信息

  • 批准号:
    1237240
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-15 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

This Innovation Corps proposal begins to translate basic science results from NSF-funded research into commercial applications in next generation, environmentally sustainable agriculture. The technology goal is the development of nitrate sensors for field applications in large-scale industrial agriculture, to monitor and control fertilizer utilization and nitrate pollutant generation from fertilizer usage. The overall goal is to simultaneously maximize agricultural productivity, optimize fertilizer usage and minimize environmental impacts resulting from fertilizer use. The proposed I-Corps funding will provide a 6-month effort to demonstrate proof-of-concept that proprietary compounds can be incorporated into a solid matrix (e.g., polymer thin films) to provide an optical readout that is sensitive for nitrate in the presence of other common interfering anions and natural organic matter.Preserving the environment and developing agricultural products that do not harm unintended targets were recently cited as grand challenges for the chemical sciences. This translational research will enable a team of entrepreneurs and scientists to evaluate a potential product that could reduce cost, energy usage and environmental damage in the multi-billion dollar per year agriculture business.
这个创新团队的提议开始将NSF资助的研究的基础科学成果转化为下一代环境可持续农业的商业应用。该技术的目标是开发硝酸盐传感器,用于大规模工业化农业的现场应用,以监测和控制肥料利用和肥料使用产生的硝酸盐污染物。总体目标是同时最大限度地提高农业生产力,优化化肥使用,并尽量减少化肥使用对环境的影响。 拟议的I-Corps资金将提供为期6个月的努力,以证明专有化合物可以掺入固体基质(例如,聚合物薄膜)以提供在其它常见干扰阴离子和天然有机物质存在下对硝酸盐敏感的光学读出。保护环境和开发不伤害非预期目标的农产品最近被列为化学科学的重大挑战。这项转化研究将使一个由企业家和科学家组成的团队能够评估一种潜在的产品,这种产品可以在每年数十亿美元的农业业务中降低成本、能源使用和环境破坏。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Darren Johnson其他文献

Autistic traits and borderline personality disorder traits are positively correlated in UK and US adult men and women
英国和美国成年男性和女性的自闭症特征和边缘性人格障碍特征呈正相关
  • DOI:
    10.1016/j.paid.2023.112287
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    G. Richards;SallyAnn Kelly;Darren Johnson;John E. Galvin
  • 通讯作者:
    John E. Galvin
Technique for selecting capsular tightness in repair of anterior-inferior shoulder instability
  • DOI:
    10.1016/s1058-2746(95)80019-0
  • 发表时间:
    1995-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jon J.P. Warner;Darren Johnson;Mark Miller;David N.M. Caborn
  • 通讯作者:
    David N.M. Caborn
Dynamic Knee Joint Stiffness During Bilateral Lower Extremity Landing 6 Months after ACL Reconstruction
ACL 重建后 6 个月双侧下肢着地时动态膝关节僵硬
  • DOI:
    10.2139/ssrn.4058993
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Benjamin D. Brightwell;M. Samaan;Darren Johnson;B. Noehren
  • 通讯作者:
    B. Noehren
Establishment of baseline cytology metrics in nestling American kestrels (<em>Falco sparverius</em>): Immunomodulatory effects of the flame retardant isopropylated triarylphosphate isomers
  • DOI:
    10.1016/j.envint.2021.106779
  • 发表时间:
    2021-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jill A. Jenkins;Brooke A. Baudoin;Darren Johnson;Kim J. Fernie;Heather M. Stapleton;Natalie K. Karouna-Renier
  • 通讯作者:
    Natalie K. Karouna-Renier
An exploration of treatment providers experiences of delivering a high intensity intervention, with violent offenders
探索治疗提供者对暴力犯罪者进行高强度干预的经验

Darren Johnson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Darren Johnson', 18)}}的其他基金

Dynamic covalent self-assembly and self-sorting of 2-dimensional and 3-dimensional nanohoops and cages
二维和三维纳米环和笼的动态共价自组装和自排序
  • 批准号:
    2003928
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
RUI: Evaluating selection via ocean acidification and evolutionary responses of two coastal fishes
RUI:通过海洋酸化和两种沿海鱼类的进化反应评估选择
  • 批准号:
    1948975
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
EAGER SitS: Sensors and Materials for In-field Soil Analysis of Nitrate and Other Oxoanions
EAGER SitS:用于硝酸盐和其他含氧阴离子现场土壤分析的传感器和材料
  • 批准号:
    1841606
  • 财政年份:
    2018
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
Supramolecular Self-Assembly and Capture as a New Route to 3D Cyclophanes
超分子自组装和捕获作为 3D 环芳的新途径
  • 批准号:
    1609926
  • 财政年份:
    2016
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
CAREER: Supramolecular Main Group Coordination Chemistry
职业:超分子主基配位化学
  • 批准号:
    0545206
  • 财政年份:
    2006
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant

相似海外基金

Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer
用于前列腺癌鉴别诊断的 MRI 造影剂的商业化
  • 批准号:
    10704488
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
Development of an Educational Product for Accelerating Solutions for Commercialization and Entrepreneurial Development (ASCEND) in Western IDeA States
开发教育产品以加速西部 IDeA 州的商业化和创业发展 (ASCEND) 解决方案
  • 批准号:
    10546242
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
ADVANCE Partnership: New Jersey Equity in Commercialization Collective (NJECC)
ADVANCE 合作伙伴关系:新泽西州股权商业化集体 (NJECC)
  • 批准号:
    2300380
  • 财政年份:
    2022
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: New Jersey Equity in Commercialization Collective (NJECC)
ADVANCE 合作伙伴关系:新泽西州股权商业化集体 (NJECC)
  • 批准号:
    2121941
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
    Continuing Grant
Commercialization, Adoption, Licensing and Manufacture of Exersides Refraints
Exersides 的商业化、采用、许可和制造
  • 批准号:
    10260567
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
Improved Methods and Commercialization of Native Mass Spectrometry by Capillary Vibrating Sharp-edge Spray Ionization (cVSSI)
毛细管振动锐边喷雾电离 (cVSSI) 天然质谱的改进方法和商业化
  • 批准号:
    10256885
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple Myeloma
新型多发性骨髓瘤分子靶向成像剂的开发和商业化
  • 批准号:
    10885315
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
Commercialization, Adoption, Licensing and Manufacture of Exersides Refraints
Exersides 的商业化、采用、许可和制造
  • 批准号:
    10516414
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple Myeloma
新型多发性骨髓瘤分子靶向成像剂的开发和商业化
  • 批准号:
    10451065
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple Myeloma
新型多发性骨髓瘤分子靶向成像剂的开发和商业化
  • 批准号:
    10155735
  • 财政年份:
    2021
  • 资助金额:
    $ 5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了